Study wrapper · #1280
Longitudinal Changes in Body Composition, Adaptive Thermogenesis and Muscle Strength in Patients with Obesity Treated with Semaglutide.
Editor's note
The interesting nuance is the split between absolute and relative muscle measures: lean mass fell in the semaglutide arm while the standardised muscle index and relative grip strength improved, which argues against reading absolute lean-mass loss as functional decline on its own. Design limits are real, though: single centre, retrospective, non-randomised, 83 patients in total, with body composition by bioelectrical impedance rather than DXA or MRI, so group differences are adjusted rather than eliminated. The adaptive-thermogenesis result also rests on a predictive equation derived from this same small cohort, which caps how far it generalises.
Plain-language abstract
At a Spanish obesity clinic, 44 adults on semaglutide plus a lifestyle programme were compared retrospectively with 39 adults on the lifestyle programme alone over 12 months. The semaglutide group lost more weight, more waist circumference and more fat mass; they also lost absolute muscle and fat-free mass, yet an age- and BMI-standardised muscle index improved markedly and grip strength relative to body weight went up. Resting energy expenditure fell in both groups by more than body-composition change alone would explain, with no significant difference between them.